References
- World Health Organization. Global tuberculosis report
2015. Geneva, Switzerland: World Health Organization.2015. Google
Scholar
- World Health Organization. Tuberculosis country
profiles report 2015: Senegal tuberculosis profile.
Geneva, Switzerland: World Health Organization.2015. Google
Scholar
- Hillemann D, Rusch-Gerdes S, Boehme C, Richter E. Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. Journal of clinical microbiology. 2011; 49(4): 1202-5. PubMed | Google Scholar
- Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F et al. Rapid molecular detection of tuberculosis and rifampin resistance. The New England journal of medicine. 2010; 363(11): 1005-15. PubMed | Google Scholar
- World Health Organization. Policy Statement: Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF system. Geneva, Switzerland: World Health Organization.2015. PubMed | Google Scholar
- Tortoli E, Russo C, Piersimoni C, Mazzola E, Dal Monte P, Pascarella M et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. The European respiratory journal. 2012; 40(2): 442-7. PubMed | Google Scholar
- Lawn SD, Zumla AI. Diagnosis of extrapulmonary tuberculosis using the Xpert((R)) MTB/RIF assay. Expert review of anti-infective therapy. 2012; 10(6): 631-5. PubMed | Google Scholar
- Kent PT, Kubica GP. Public Health Mycobacteriology: a Guide for the Level III Laboratory. Centers for Disease Control, U.S. Department of Health and Human Services, Atlanta, Georgia.1985. Google Scholar
- Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. Journal of clinical microbiology. 2010; 48(1): 229-37. PubMed | Google Scholar
- Piatek AS, Telenti A, Murray MR, El-Hajj H, Jacobs WR Jr, Kramer FR et al. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrobial agents and chemotherapy. 2000; 44(1): 103-10. PubMed | Google Scholar
- World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Geneva, Switzerland: World Health Organization.2015. Google Scholar
- Becton Dickinson Diagnostic Systems. BD MGITTM TBc ID identification test package insert, BD document L8085917(01). BD Diagnostic Systems, Sparks, MD.2009. Google Scholar
- van Soolingen D, Hermans PW, de Haas PE, Soll DR, van Embden JD. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. Journal of clinical microbiology. 1991 ; 29(11) :2578-86. PubMed | Google Scholar
- Hain Lifescience. Protocole d'utilisation du test GenoTypeŽ MTBDRplus version 2.0. 2012.http://www.moleculartb.org/gb/pdf/protocols/Protocole_GenoType_MTBDRplus_V2.pdf. Accessed on June 15, 2016
- Ozkutuk N, Surucuoglu S. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting. Mikrobiyoloji bulteni. 2014; 48(2): 223-32. PubMed | Google Scholar
- Zmak L, Jankovic M, Jankovic VK. Evaluation of Xpert MTB/RIF assay for rapid molecular diagnosis of tuberculosis in a two-year period in Croatia. International journal of mycobacteriology. 2013; 2(3):179-82. PubMed | Google Scholar
- Scott LE, Beylis N, Nicol M, Nkuna G, Molapo S, Berrie L et al. Diagnostic accuracy of Xpert MTB/RIF for extrapulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South Africa. Journal of clinical microbiology. 2014; 52(6): 1818-23. PubMed | Google Scholar
- Blaich A, Frei R. Performance of the Xpert MTB/RIF assay on nonrespiratory specimens and accuracy of this assay for detection of rifampin resistance in a low-prevalence setting. Journal of clinical microbiology. 2014; 52(2): 706. PubMed | Google Scholar
- Iram S, Zeenat A, Hussain S, Wasim Yusuf N, Aslam M. Rapid diagnosis of tuberculosis using Xpert MTB/RIF assay - Report from a developing country. Pakistan journal of medical sciences. 2015; 31(1): 105-10. PubMed | Google Scholar
- Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? Journal of clinical microbiology. 2011; 49(7): 2540-5. PubMed | Google Scholar
- Marlowe EM, Novak-Weekley SM, Cumpio J, Sharp SE, Momeny MA, Babst A et al. Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. Journal of clinical microbiology. 2011; 49(4):1621-3. PubMed | Google Scholar
- Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. The European respiratory journal. 2014; 44(2): 435-46. PubMed | Google Scholar
- Sharma SK, Kohli M, Chaubey J, Yadav RN, Sharma R, Singh BK et al. Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India. The European respiratory journal. 2014; 44(4): 1090-3. PubMed | Google Scholar
- Theron G, Peter J, Calligaro G, Meldau R, Hanrahan C, Khalfey H et al. Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments. Scientific reports. 2014; 4: 5658. PubMed | Google Scholar
- Kim YW, Kwak N, Seong MW, Kim EC, Yoo CG, Kim YW et al. Accuracy of the Xpert(R) MTB/RIF assay for the diagnosis of extra-pulmonary tuberculosis in South Korea. The international journal of tuberculosis and lung disease: The official journal of the International Union against Tuberculosis and Lung Disease. 2015; 19(1): 81-6. PubMed | Google Scholar
- Gu Y, Wang G, Dong W, Li Y, Ma Y, Shang Y et al. Xpert MTB/RIF and GenoType MTBDRplus assays for the rapid diagnosis of bone and joint tuberculosis. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2015; 36: 27-30. PubMed | Google Scholar
- Williamson DA, Basu I, Bower J, Freeman JT, Henderson G, Roberts SA. An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Diagnostic microbiology and infectious disease. 2012; 74(2): 207-9. PubMed | Google Scholar
- Ocheretina O, Byrt E, Mabou MM, Royal-Mardi G, Merveille YM, Rouzier V et al. False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load. Diagnostic microbiology and infectious disease. 2016; 85(1): 53-5. PubMed | Google Scholar
- Centers for Disease C, Prevention. Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use - United States, 2013. MMWR Morbidity and mortality weekly report. 2013 ; 62(41): 821-7. PubMed | Google Scholar